Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

02/08/2017 07:00

Aug 2 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             2.71                2.89             10.93     
                 (-5.9 pct)          (+2.4 pct)       (+0.9 pct)   
  Operating        134 mln             125 mln          100 mln    
                 (+7.3 pct)          (-1.0 pct)       (+14.5 pct)  
  Recurring        150 mln             130 mln          80 mln     
                 (+14.7 pct)         (-9.6 pct)       (-22.3 pct)  
  Net              99 mln              85 mln           30 mln     
                 (+16.5 pct)         (-5.2 pct)       (-68.3 pct)  
  EPS             2.87 yen            2.46 yen         0.86 yen    
  Ann Div                             3.00 yen                     
  -Q2 div                                NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T 
  ((Tokyo Headline News Desk +813 6441 1812))